Related Experiment Video

Updated: Jun 8, 2026

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

MDM2 antagonist Nutlin-3 enhances bortezomib-mediated mitochondrial apoptosis in TP53-mutated mantle cell lymphoma

Linhua Jin1, Yoko Tabe, Kensuke Kojima

  • 1Department of Clinical Pathology, Juntendo University School of Medicine, Tokyo, Japan.

Cancer Letters
|September 21, 2010
PubMed

Insights

The combination of Nutlin-3 and bortezomib shows synergistic effects in mantle cell lymphoma (MCL) cells. This approach offers potential treatment for refractory MCL, regardless of TP53 mutation status.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Mantle cell lymphoma (MCL) is an aggressive non-Hodgkin lymphoma.
  • TP53 mutations and innate sensitivity to bortezomib influence treatment outcomes in MCL.
  • Chemorefractory MCL presents a significant therapeutic challenge.

Purpose of the Study:

  • To investigate the synergistic effect of MDM2 inhibitor Nutlin-3 and proteasome inhibitor bortezomib in MCL cells.
  • To elucidate the mechanisms underlying the combination therapy's efficacy in both TP53-mutant and wild-type MCL cells.
  • To evaluate the therapeutic potential of this combination for refractory MCL.

Main Methods:

  • Treatment of MCL cell lines with Nutlin-3 and bortezomib, individually and in combination.
  • Assessment of cell viability, cytotoxicity, cell cycle progression, and apoptosis.
  • Analysis of key proteins involved in apoptosis, including NOXA, MCL-1, BAX, BAK, and caspases.
  • Evaluation of TP53 mutation status and innate bortezomib sensitivity.

Main Results:

  • A pronounced synergistic growth-inhibitory effect was observed with the Nutlin-3/bortezomib combination in MCL cells.
  • In TP53-mutant MCL cells resistant to bortezomib, the combination induced cytotoxicity via the mitochondrial apoptotic pathway, involving NOXA upregulation and MCL-1 sequestration.
  • In wild-type TP53 MCL cells sensitive to bortezomib, the combination induced G0/G1 cell cycle arrest and enhanced apoptosis.

Conclusions:

  • The combination of Nutlin-3 and bortezomib demonstrates significant synergistic efficacy in MCL cells.
  • This combination therapy effectively targets both bortezomib-sensitive and resistant MCL, including those with TP53 mutations.
  • Nutlin-3 and bortezomib represent a promising therapeutic strategy for treating chemorefractory MCL.

More Related Videos

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...